tiprankstipranks
Creative Medical Technology Holdings (CELZ)
NASDAQ:CELZ
US Market

Creative Medical Technology Holdings (CELZ) Financial Statements

Compare
177 Followers

Creative Medical Technology Holdings Financial Overview

Creative Medical Technology Holdings's market cap is currently $5.60M. The company's EPS TTM is $-3.711; its P/E ratio is ―; Creative Medical Technology Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 11.00K$ 9.00K$ 88.60K$ 87.75K$ 164.50K
Gross Profit$ 6.60K$ 5.40K$ 60.11K$ 39.80K$ 113.90K
Operating Income$ -5.63M$ -5.62M$ -10.24M$ -3.13M$ -1.11M
EBITDA$ -5.63M$ -5.53M$ -10.15M$ -3.03M$ -1.05M
Net Income$ -5.49M$ -5.29M$ -10.04M$ 14.93M$ -37.55M
Balance Sheet
Cash & Short-Term Investments$ 5.94M$ 9.99M$ 18.40M$ 10.72M$ 98.01K
Total Assets$ 6.67M$ 10.72M$ 19.19M$ 11.27M$ 717.77K
Total Debt$ 0.00$ 14.19K$ 14.19K$ 14.19K$ 788.70K
Net Debt$ -5.94M$ -3.47M$ -18.38M$ -10.71M$ 690.69K
Total Liabilities$ 327.64K$ 371.39K$ 3.32M$ 1.05M$ 40.52M
Stockholders' Equity$ 6.34M$ 10.34M$ 15.86M$ 10.22M$ -39.80M
Cash Flow
Free Cash Flow$ -5.30M$ -8.13M$ -7.80M$ -2.22M$ -684.56K
Operating Cash Flow$ -5.30M$ -8.03M$ -7.80M$ -2.22M$ -434.56K
Investing Cash Flow$ 6.32M$ 3.45M$ -10.08M$ 0.00$ -250.00K
Financing Cash Flow$ 1.45M$ -270.95K$ 15.47M$ 12.84M$ 693.92K
Currency in USD

Creative Medical Technology Holdings Earnings and Revenue History

Creative Medical Technology Holdings Debt to Assets

Creative Medical Technology Holdings Cash Flow

Creative Medical Technology Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis